Magnetic beads nucleic acid extraction technology
South Africa
  Overview of innovation
              The bottleneck to most of the molecular (PCR) testing is due to lack of nucleic acid extraction kits. Where available, the possibility of automation enhances the speed with which one can access high throughput extraction. Therefore, development and manufacture of efficient extraction reagents is the first step towards pandemic/infectious disease outbreak readiness. The lessons from Covid-19 outbreak should include countries readying themselves against such outbreaks by manufacturing their own reagents and having the ability to ramp up production when necessary. Our product development and manufacturing is one such step towards self sufficiency in infectious disease readiness.
          Name of Developer
              Phiyani Lebea
          Primary Organisation
              Tokabio (Pty) Ltd
          Was this innovation co-created? 
              No
          Innovation Area/Category
          Diagnostics
              Technology Readiness Level
              TRL 7 – Refined prototype created
          Intellectual Property
              Yes
          Type of Intellectual Property protection
          Know how
          Trade secret
              Opportunity Type
          Funding
          Manufacturing